Results 11 to 20 of about 8,392 (166)

Synergistic Cooperation between the β-Catenin Signaling Pathway and Steroidogenic Factor 1 in the Activation of the Mullerian Inhibiting Substance Type II Receptor [PDF]

Journal of Biological Chemistry, 2003
Mullerian inhibiting substance type II receptor (MISRII) is a member of the transforming growth factor-beta superfamily. Mutations in mullerian inhibiting substance (MIS) or MISRII cause male sexual abnormalities, persistent mullerian duct syndrome, and pseudohermaphroditism.
Anwar, Hossain, Grady F, Saunders
openaire   +4 more sources

Application areas of modern automated methods of anti-Müllerian hormone evaluation

Репродуктивная эндокринология, 2021
Anti-Müllerian hormone (AMН) is a glycopeptide of the transforming growth factors β-family, used in many medical fields. Understanding of the biological role of AMH at norm and at pathology such as polycystic ovary syndrome (PCOS) is expanding.
O.A. Burka, T.M. Tutchenko, O.M. Kudlai, T.V. Shevchuk, O.V. Protsenko, O.M. Makarovets   +5 more
doaj   +1 more source

Mullerian Inhibiting Substance Regulates Androgen-Induced Gene Expression and Growth in Prostate Cancer Cells through a Nuclear Factor-κB-Dependent Smad-Independent Mechanism [PDF]

Molecular Endocrinology, 2006
AbstractMullerian inhibiting substance (MIS), a member of the TGFβ superfamily, causes regression of the Mullerian duct in male embryos. The presence of MIS type II and type I receptors in tissues and cell lines derived from the prostate suggests that prostate is a likely target for MIS.
Trinh T, Tran, Dorry L, Segev, Vandana, Gupta, Hirofumi, Kawakubo, Giminna, Yeo, Patricia K, Donahoe, Shyamala, Maheswaran   +6 more
openaire   +2 more sources

Regulation of ovarian function: the role of anti-Mullerian hormone [PDF]

, 2002
Anti-Mullerian hormone (AMH), also known as Mullerian inhibiting substance, is a member of the transforming growth factor beta superfamily of growth and differentiation factors.
Durlinger, A.L.L. (Alexandra), Themmen, A.P.N. (Axel), Visser, J.A. (Jenny)   +2 more
core   +2 more sources

Persistent Mullerian duct syndrome with testicular seminoma: A report of two cases

Indian Journal of Urology, 2011
Persistent Mullerian duct syndrome is a rare form of male pseudohermaphroditism, characterized by the presence of the Mullerian duct structures in an otherwise phenotypically as well as genotypically normal male.
Renuka V Inuganti, G Saila Bala, Y Kiran Kumar, Y Krishna Bharathi   +3 more
doaj   +1 more source

Müllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumors [PDF]

, 2014
Müllerian inhibiting substance (MIS), also called anti-Müllerian hormone (AMH), is a member of the transforming growth factor-β super-family of growth and differentiation response modifiers.
Donahoe, Patricia K., Kim, Jang Heub, MacLaughlin, David T.   +2 more
core   +1 more source

Anti-müllerian hormone is not associated with cardiometabolic risk factors in adolescent females [PDF]

, 2013
<p>Objectives: Epidemiological evidence for associations of Anti-Müllerian hormone (AMH) with cardiometabolic risk factors is lacking. Existing evidence comes from small studies in select adult populations, and findings are conflicting. We aimed to
A Bayrak, A La Marca, A La Marca, A Piouka, Abigail Fraser, AC Hergenroeder, AM Wallace, Andrea Cignarella, AZ Steiner, B Schwartz, BC Gladen, C Levy-Marchal, C Mattocks, C Villarroel, CJ Riddoch, CP Hagen, CP Hagen, Debbie A. Lawlor, E Buyuk, E Codner, EB Johnstone, Emma L. Anderson, EW Freeman, FB Hu, GF Kerkhof, GS Berenson, Hany Lashen, HM Blanck, HT Park, HY Woo, IA van Rooij, JC Rockett, JM Raitakari OT, JP Strong, KR Hansen, L Aksglaede, LG Nardo, M Hickey, M Juonala, MC Chu, MJ Chen, N Gungor, N Morris, Naveed Sattar, P McCarron, P Skalba, R Fleming, R Hart, Richard Fleming, RL Thomson, S Palomba, Scott M. Nelson, SM Nelson, T Freour, T Kelsey, T Sir-Petermann, TW Kelsey, WA Marshall, William McNally, WJK Hehenkamp, WT Friedewald, YH Lin, YT van der Schouw   +62 more
core   +5 more sources

Expression of Anti-Mullerian Hormone Protein during Early Follicular Development in the Primate Ovary in Vivo Is Influenced by Suppression of Gonadotropin Secretion and Inhibition of Vascular Endothelial Growth Factor [PDF]

Endocrinology, 2007
Anti-Mullerian hormone (AMH) plays a role during early follicular development and selection. The aim of this study was to determine the pattern of AMH protein expression in the marmoset ovary and to investigate the effects of inhibition of gonadotropins or vascular endothelial growth factor (VEGF) activity on AMH expression in vivo.
Fiona H, Thomas, Evelyn E, Telfer, Hamish M, Fraser   +2 more
openaire   +2 more sources

Genome-wide association study identifies common and low-frequency variants at the AMHgene locus that strongly predict serum AMH levels in males [PDF]

, 2016
Anti-Müllerian hormone (AMH) is an essential messenger of sexual differentiation in the foetus and is an emerging biomarker of postnatal reproductive function in females.
Day, Felix R., Lawlor, Debbie A., McMahon, George, Nelson, Scott M., Perry, John R.B., Ring, Susan M.   +5 more
core   +1 more source

Quercetin alleviates cyclophosphamide-induced premature ovarian insufficiency in mice by reducing mitochondrial oxidative stress and pyroptosis in granulosa cells

Journal of Ovarian Research, 2022
Background Exposure to cyclophosphamide (CTX) induces premature ovarian insufficiency (POI). Quercetin is a natural flavonoid that exhibits anti-inflammatory and antioxidant properties, and its antioxidant activity is correlated with POI.
Yun Chen, Ying Zhao, Chenyun Miao, Liuqing Yang, Ruye Wang, Bixia Chen, Qin Zhang   +6 more
doaj   +1 more source